NKTR
NASDAQ
$64.84
Nektar Therapeutics (NKTR)
Nektar Therapeutics is a biopharmaceutical company. The company is headquartered in San Francisco, California with additional operations in Huntsville, Alabama and Hyderabad, India.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $153.25 (+136.35%)
Market Cap
$1.69B
PEG Ratio
0.31
Free Cash Flow Yield
-12.07%
Beta (5Y)
1.81
Price Chart
Valuation
Market Cap$1.69B
Forward P/E34.01
PEG0.31
P/S41.48
P/B3.94
Profitability
Total Revenue (TTM)$56M
Gross Profit (TTM)$56M
EBITDA-$126M
Profit Margin-284.2%
Operating Margin-352.2%
EPS-$9.07
Financial Health
Debt-to-Equity24.9%
Free Cash Flow Yield-12.07%
Growth & Risk
EPS 5Y CAGR-24.01%
Revenue 5Y CAGR-15.08%
FCF 5Y CAGR-8.70%
Beta (5Y)1.81
Sharpe Ratio1.35